4//SEC Filing
Jorgensen Nathan D. 4
Accession 0001209191-22-048724
CIK 0001817229other
Filed
Sep 5, 8:00 PM ET
Accepted
Sep 6, 4:14 PM ET
Size
7.5 KB
Accession
0001209191-22-048724
Insider Transaction Report
Form 4
Jorgensen Nathan D.
Chief Financial Officer
Transactions
- Award
Common Stock
2022-09-01+86,000→ 115,269 total - Award
Employee Stock Option (right to buy)
2022-09-01+86,000→ 86,000 totalExercise: $5.31Exp: 2032-08-31→ Common Stock (86,000 underlying)
Footnotes (2)
- [F1]Represents the number of shares underlying restricted stock units ("RSUs"). Each RSU represents the contingent right to receive one share of common stock of the Issuer. The RSUs vest in four equal installments on each of March 1, 2023, September 1, 2023, March 1, 2024 and September 1, 2024, in each case, subject to the Reporting Person's continued service as of each such date.
- [F2]The shares shall vest and become exercisable in a series of 24 successive equal monthly installments beginning on October 1, 2022, in each case subject to the Reporting Person's continued service as of each such date.
Documents
Issuer
Vor Biopharma Inc.
CIK 0001817229
Entity typeother
Related Parties
1- filerCIK 0001842523
Filing Metadata
- Form type
- 4
- Filed
- Sep 5, 8:00 PM ET
- Accepted
- Sep 6, 4:14 PM ET
- Size
- 7.5 KB